Skip to content

Rehabiliation Using HUBER 360 to Reduce the Risk of Falls

Investigation of the Effectiveness of Rehabilitation Using the HUBER 360 Tool to Reduce the Risk of Falls in People in Pathological Situations Requiring Functional Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04687293
Acronym
HUBER-FALLS
Enrollment
32
Registered
2020-12-29
Start date
2020-12-09
Completion date
2022-11-02
Last updated
2023-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Therapy, Fall, Quality of Life, Rehabilitation, Treatment Outcome

Keywords

Huber

Brief summary

Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce the risk of falls. Subjects: any patient 1) benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF, Belgium; 2) presenting a pathological situation justifying functional rehabilitation with HUBER 360®; 3) presenting any pathology not constituting an exclusion criterion; 4) giving informed consent to research will be include in this 8-week interventional trial. Design: randomized open-label trial. Patients will be randomized into the intervention group (HUBER trainig, 45 minutes of training, twice a week during 8 weeks) or in the control group (standard care). Outcomes: the effect of the training will be measured on the Time-Up-and-Go test, on the Short-Physical performance battery test and on quality of life.

Interventions

DEVICEHUBER (LPG Systems, France)

The HUBER® device consists of an oval motorized platform, which performs rotating, oscillatory movements with a controlled amplitude and speed. It also comprises, two large handles with force sensors, mounted on a movable column. Its originality is based on its capacity to capture simultaneously the subjects' balance, core stability, core strength and total body strength; and adapt the training accordingly. Indeed, the platform interferes with the balance of the patient who must continually adjust his/her posture by exerting isometric pushing and pulling efforts with the arms. As a result, the device provides postural and muscle adaptation with visual feedback. Due to the constant adaptation of the device, it is thought to enhance muscular strength and improve neuromuscular coordination simultaneously.

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF * Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360® * Patient presenting any pathology not constituting an exclusion criterion * Patient giving informed consent to research.

Exclusion criteria

* Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ; * Joint inflammation; * Rheumatic disease in acute phase; * Recent trauma, infection of the musculoskeletal system; * Fever; * Venous thrombosis ; * Discopathy in acute phase; * Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems; * Cardiovascular diseases and any progressive, chronic, counter-indicative disease; * Large anatomical deformities.

Design outcomes

Primary

MeasureTime frameDescription
Risk of falls, in seconds8 weeksMeasured with Timed-Up-and Go test

Secondary

MeasureTime frameDescription
Physical performance8 weeksShort Physical Performance Battery test (SPPB test). The test is scored from 0 (lower physical performance) to 12 (highest physical performance)
Quality of life, measured with the Short Form-36 questionnaire8 weeksSF-36 generic quality of life questionnaire. The score obtained from this questionnaire is composed with a Physcial component Scale (PMS) and a Mental component scale (MCS). Results are scored from 0 (worst quality of life) to 100 (best quality of life).
Utility score using the EuroQol- 5 Dimension questionnaire8 weeksDescriptive data from the 5 dimensions can be used to generate a health-related quality of life profile for the subject. The questionnaire is scored from 0 (worst health state imaginable) to 100 (best health state imaginable).

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026